Joint Effect of Estrogen Receptor β Sequence Variants and Endogenous Estrogen Exposure on Breast Cancer Risk in Chinese Women

作者: Yu-Tang Gao , Wei Zheng , S. Lilly Zheng , Xiao-Ou Shu , Jianfeng Xu

DOI:

关键词: Breast cancerRisk factorEstrogenMammary glandInternal medicineSex hormone-binding globulinSingle-nucleotide polymorphismBiologyEstrogen receptorEstrogen receptor betaEndocrinology

摘要: Long-term estrogen exposure and family history of breast cancer are the two factors that most consistently found to be associated with risk. Sequence variants in genes involved synthesis, metabolism, signal transduction may account, part, for this observation. Using data DNA samples from Shanghai Breast Cancer Study, we tested hypothesis sequence receptor beta gene (ESR2) increased risk cancer, particularly among women who have a high level long-term endogenous exposure. Direct sequencing ESR2 30 Chinese revealed eight variants. Association analysis six common 1134 cases 1235 controls provided evidence positive associations between single nucleotide polymorphisms (SNPs), [C(14206)T C(33390)G], postmenopausal women. Evidence stronger association was SNP [C(33390)G] long duration (> or =34 years) menstruation (odds ratio, 2.37; 95% confidence interval, 1.18-4.77). A potential synergistic effect several steroid sex hormones observed, 3-4-fold elevated CG GG genotype combined hormone low binding globulin. Our results consistent joint on

参考文章(33)
Jay R. Harris, Marc E. Lippman, Umberto Veronesi, Walter Willett, Breast cancer: (Second of three parts) The New England Journal of Medicine. ,vol. 327, pp. 390- 398 ,(1992) , 10.1056/NEJM199208063270606
Yu-Tang Gao, Wei Zheng, Wanqing Wen, Xiao-Ou Shu, Qiuyin Cai, Jeffrey R Smith, Fan Jin, Association of breast cancer risk with a GT dinucleotide repeat polymorphism upstream of the estrogen receptor-alpha gene. Cancer Research. ,vol. 63, pp. 5727- 5730 ,(2003)
Richard A King, Jerome I Rotter, Arno G Motulsky, None, The genetic basis of common diseases. The genetic basis of common diseases.. ,(2002)
Yu-Tang Gao, Jia-Rong Cheng, Wei Zheng, Wanqing Wen, Xiao-Ou Shu, Qi Dai, Qiuyin Cai, Fan Jin, Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast Cancer Study. Cancer Epidemiology, Biomarkers & Prevention. ,vol. 12, pp. 853- 859 ,(2003)
MM De Jong, IM Nolte, GJ Te Meerman, WTA Van der Graaf, JC Oosterwijk, JH Kleibeuker, M Schaapveld, EGE De Vries, Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. Journal of Medical Genetics. ,vol. 39, pp. 225- 242 ,(2002) , 10.1136/JMG.39.4.225
Herbert Yu, Xiao-Ou Shu, Runhua Shi, Qi Dai, Fan Jin, Yu-Tang Gao, Benjamin D.L. Li, Wei Zheng, Plasma sex steroid hormones and breast cancer risk in Chinese women. International Journal of Cancer. ,vol. 105, pp. 92- 97 ,(2003) , 10.1002/IJC.11034
W. Porter, B. Saville, D. Hoivik, S. Safe, Functional Synergy between the Transcription Factor Sp1 and the Estrogen Receptor Molecular Endocrinology. ,vol. 11, pp. 1569- 1580 ,(1997) , 10.1210/MEND.11.11.9916
Robert E. Coleman, Current and future status of adjuvant therapy for breast cancer Cancer. ,vol. 97, pp. 880- 886 ,(2003) , 10.1002/CNCR.11124
Barbara S. Hulka, Patricia G. Moorman, Breast cancer: hormones and other risk factors. Maturitas. ,vol. 38, pp. 103- 113 ,(2001) , 10.1016/S0378-5122(00)00196-1
J Cuzick, T Powles, U Veronesi, J Forbes, R Edwards, S Ashley, P Boyle, Overview of the main outcomes in breast-cancer prevention trials. The Lancet. ,vol. 361, pp. 296- 300 ,(2003) , 10.1016/S0140-6736(03)12342-2